Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 170 Records) |
| Query Trace: Hypertension and EGFR[original query] |
|---|
| SLC12A3 Variation and Renal Function in Chinese Patients With Hypertension. Frontiers in medicine 2022 7 9 863275. Huang Chin-Chou, Chung Chia-Min, Yang Chih-Yu, Leu Hsin-Bang, Huang Po-Hsun, Lin Liang-Yu, Wu Tao-Cheng, Lin Shing-Jong, Pan Wen-Harn, Chen Jaw-W |
| Effect of NOTCH3 EGFr Group, Sex, and Cardiovascular Risk Factors on CADASIL Clinical and Neuroimaging Outcomes. Stroke 2022 7 53 (10): 3133-3144. Hack Remco J, Cerfontaine Minne N, Gravesteijn Gido, Tap Stephan, Hafkemeijer Anne, van der Grond Jeroen, Witjes-Ané Marie-Noëlle, Baas Frank, Rutten Julie W, Lesnik Oberstein Saskia A |
| Aspartate aminotransferase to alanine aminotransferase ratio and the risk of diabetic nephropathy progression in patients with type 2 diabetes mellitus: A biopsy-based study. Journal of diabetes and its complications 2022 7 36 (8): 108235. Wu Yucheng, Liu Fa |
| Non-diabetic urine glucose in idiopathic membranous nephropathy. Renal failure 2022 7 44 (1): 1104-1111. Liu Lingling, Zuo Ke, Le Weibo, Lu Manman, Liu Zhihong, Xu Weiw |
| Addition of Bevacizumab to Erlotinib as First-Line Treatment of Patients With EGFR-Mutated Advanced Nonsquamous NSCLC: The BEVERLY Multicenter Randomized Phase 3 Trial. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2022 Jun . Piccirillo Maria Carmela, Bonanno Laura, Garassino Marina Chiara, Esposito Giovanna, Dazzi Claudio, Cavanna Luigi, Burgio Marco Angelo, Rosetti Francesco, Rizzato Simona, Morgillo Floriana, Cinieri Saverio, Veccia Antonello, Papi Maximilan, Tonini Giuseppe, Gebbia Vittorio, Ricciardi Serena, Pozzessere Daniele, Ferro Alessandra, Proto Claudia, Costanzo Raffaele, D'Arcangelo Manolo, Proietto Manuela, Gargiulo Piera, Di Liello Raimondo, Arenare Laura, De Marinis Filippo, Crinò Lucio, Ciardiello Fortunato, Normanno Nicola, Gallo Ciro, Perrone Francesco, Gridelli Cesare, Morabito Alessand |
| Erlotinib with or without bevacizumab as a first-line therapy for patients with advanced nonsquamous epidermal growth factor receptor-positive non-small cell lung cancer: Exploratory subgroup analyses from the phase II JO25567 study. Thoracic cancer 2022 Jun . Hosomi Yukio, Seto Takashi, Nishio Makoto, Goto Koichi, Yamamoto Noboru, Okamoto Isamu, Tajima Kosei, Kajihara Yusuke, Yamamoto Nobuyu |
| Are polymorphisms affecting serum urate, renal urate handling and alcohol intake associated with co-morbidities in gout cases? A case-control study using data from the UK Biobank. Rheumatology international 2022 May . Sandoval-Plata Gabriela, Morgan Kevin, Abhishek Abhish |
| Serum lipoprotein (a) associates with the risk of renal function damage in the CHCN-BTH Study: Cross-sectional and Mendelian randomization analyses. Frontiers in endocrinology 2022 12 13 1023919. Xie Yunyi, Qi Han, Li Bingxiao, Wen Fuyuan, Zhang Fengxu, Guo Chunyue, Zhang Li |
| Longitudinal effects of a common UMOD variant on kidney function, blood pressure, cognitive and physical function in older women and men. Journal of human hypertension 2022 11 . Algharably Engi Abdel-Hady, Villagomez Fuentes Linda Elizabeth, Toepfer Sarah, König Maximilian, Regitz-Zagrosek Vera, Bertram Lars, Bolbrinker Juliane, Demuth Ilja, Kreutz Reinho |
Identifying Genetic Variants and Metabolites Associated with Rapid Estimated Glomerular Filtration Rate Decline in Korea Based on Genome-Metabolomic Integrative Analysis.
Metabolites 2022 11 12 (11): . Lee Sangjun, Han Miyeun, Moon Sungji, Kim Kyungsik, An Woo Ju, Ryu Hyunjin, Oh Kook-Hwan, Park Sue |
| Clinical phenotypes and long-term outcome of kidney involvement in Erdheim-Chester histiocytosis. Kidney international 2022 11 103 (1): 177-186. Chazal Thibaud, Pegoraro Francesco, Manari Gaia, Bettiol Alessandra, Maniscalco Valerio, Gelain Elena, Charlotte Frédéric, Mazor Roei D, Renard-Penna Raphaele, Amoura Zahir, Cohen-Aubart Fleur, Haroche Julien, Izzedine Hassan, Vaglio Augus |
| Disparities in ethnicity and metabolic disease burden in referrals to nephrology. Singapore medical journal 2023 9 . Yan Ting Chua, Cheang Han Leo, Horng Ruey Chua, Weng Kin Wong, Gek Cher Chan, Anantharaman Vathsala, Ye Lu Mavis Gan, Boon Wee T |
| The efficacy and safety of chemo-free therapy in epidermal growth factor receptor tyrosine kinase inhibitor-resistant advanced non-small cell lung cancer: A single-arm, phase II study. Cancer medicine 2023 9 . Shuyang Zhang, Lu Yang, Yaning Yang, Guangjian Yang, Haiyan Xu, Xueliang Niu, Yan Wa |
| A randomized phase II study of afatinib alone or combined with bevacizumab for treating chemo-naïve patients with non-small cell lung cancer harboring EGFR mutations. Lung cancer (Amsterdam, Netherlands) 2023 8 184 107349. Takashi Ninomiya, Nobuhisa Ishikawa, Toshiyuki Kozuki, Shoichi Kuyama, Koji Inoue, Toshihide Yokoyama, Nobuhiro Kanaji, Masayuki Yasugi, Takuo Shibayama, Keisuke Aoe, Nobuaki Ochi, Kazunori Fujitaka, Masahiro Kodani, Yutaka Ueda, Kazuhiko Watanabe, Akihiro Bessho, Keisuke Sugimoto, Isao Oze, Katsuyuki Hotta, Katsuyuki Kiu |
| Low?dose anlotinib combined with EGFR?TKI can be used as an alternative for EGFR?TKI?resistant non?small cell lung cancer in elderly patients. Oncology letters 2023 7 26 (2): 323. Yi Chen, Nanyuan Jiang, Xiao Liang, Nan Chen, Yun Chen, Chen Zhang, Junfeng Shi, Renhua G |
| Efficacy and Tolerability of Ramucirumab Plus Erlotinib in Taiwanese Patients with Untreated, Epidermal Growth Factor Receptor-Mutated, Stage IV Non-small Cell Lung Cancer in the RELAY Study. Targeted oncology 2023 6 . Chao-Hua Chiu, Meng-Chih Lin, Yu-Feng Wei, Gee-Chen Chang, Wu-Chou Su, Te-Chun Hsia, Jian Su, Anne Kuei-Fang Wang, Min-Hua Jen, Tarun Puri, Jin-Yuan Sh |
| Efficacy and safety of EGFR-TKIs in combination with angiogenesis inhibitors as first-line therapy for advanced EGFR-mutant non-small-cell lung cancer: a systematic review and meta-analysis. BMC pulmonary medicine 2023 6 23 (1): 207. Di Hu, Yan-Yan Zhou, Hong-Bo Ma, Miao-Miao Tao, Qun-Zhen Huang, Zhen-Zhou Yang, Qi Zh |
| Efficacy and safety analysis of anlotinib combined with PD-1 inhibitors in advanced non-small cell lung cancer: a retrospective cohort study. Journal of thoracic disease 2023 5 15 (4): 2003-2011. Xuanting Ye, Aimi Huang, Yan Zhou, Yanbin Kuang, Weimin Wang, Aiqin Gu, Ling |
| Osimertinib combined with bevacizumab as the first-line treatment in non-small cell lung cancer patients with brain metastasis harboring epidermal growth factor receptor mutations. Thoracic cancer 2023 4 . Zhang Ling, You Yunhong, Liu Xueli, Liu Fengjuan, Nie Keke, Ji Youx |
| Association of MPPED2 gene variant rs10767873 with kidney function and risk of cardiovascular disease in patients with hypertension. Journal of human genetics 2023 2 . Zhong Yixuan, Wu Yiyi, Yang Yunyun, Chen Yu, Hui Rutai, Zhang Mei, Zhang Wei |
| Is Kidney Function Associated with Age-Related Macular Degeneration? Findings from the Asian Eye Epidemiology Consortium. Ophthalmology 2023 12 . Can Can Xue, Ralene Sim, Miao Li Chee, Marco Yu, Ya Xing Wang, Tyler Hyungtaek Rim, Park Kyu Hyung, Kang Se Woong, Su Jeong Song, Vinay Nangia, Songhomitra Panda-Jonas, Ning Li Wang, Jie Hao, Qing Zhang, Kai Cao, Mariko Sasaki, Sei Harada, Takebayashi Toru, Kawasaki Ryo, Rajiv Raman, Janani Surya, Rehana Khan, Mukharram Bikbov, Ian Y Wong, Chui Ming Gemmy Cheung, Jost B Jonas, Ching-Yu Cheng, Yih-Chung Th |
| The Clinical and Mutational Spectrum of 69 Turkish Children with Autosomal Recessive or Autosomal Dominant Polycystic Kidney Disease: A Multicenter Retrospective Cohort Study. Nephron 2023 1 1-14. Tutal Ozum, Gulhan Bora, Atayar Emine, Yuksel Selcuk, Ozcakar Z Birsin, Soylemezoglu Oguz, Saygili Seha, Caliskan Salim, Inozu Mihriban, Baskin Esra, Duzova Ali, Hayran Mutlu, Topaloglu Rezan, Ozaltin Fat |
| APOL1 Risk Variants and Acute Kidney Injury in Black Americans with COVID-19. Clinical journal of the American Society of Nephrology : CJASN 2023 1 16 (12): 1790-1796. Larsen Christopher P, Wickman Terrance J, Braga Juarez R, Matute-Trochez Luis A, Hasty Anna E, Buckner Lyndsey R, Arthur John M, Haun Randy S, Velez Juan Carlos |
| Association between Kidney Stones and CKD: A Bidirectional Mendelian Randomization Study. Journal of the American Society of Nephrology : JASN 2024 8 . Le-Ting Zhou, Ahmed E Ali, Muthuvel Jayachandran, Zejfa Haskic, Peter C Harris, Andrew D Rule, Kevin Koo, Shannon K McDonnell, Nicholas B Larson, John C Lies |
| The Importance of the FUT2 rs602662 Polymorphism in the Risk of Cardiovascular Complications in Patients after Kidney Transplantation. International journal of molecular sciences 2024 6 25 (12): . Maciej Józef Kotowski, Piotr Ostrowski, Jerzy Sie?ko, Bogus?aw Czerny, Karol Tejchman, Bogus?aw Machali?ski, Aleksandra Górska, Aleksandra E Mrozikiewicz, Anna Boga |
| Evidence for a relationship between genetic polymorphisms of the L-DOPA transporter LAT2/4F2hc and risk of hypertension in the context of chronic kidney disease. BMC medical genomics 2024 6 17 (1): 163. Paolina Crocco, Serena Dato, Rossella La Grotta, Giuseppe Passarino, Giuseppina Ro |
| Prognostic significance of SIRI in patients with late-stage lung adenocarcinoma receiving EGFR-TKI treatment. Current problems in cancer 2024 5 50 101099. Herong Wang, Wei |
| Cardiovascular events in eGFR-mutation non-small-cell lung cancer patients on osimertinib. European journal of hospital pharmacy : science and practice 2024 10 . Samuel Akaakole Mensah, Syed Ahmad, Waleed Alruwaili, Rutu Raval, Karthik Gonuguntla, Brijesh Pat |
| Afatinib plus bevacizumab combination after osimertinib resistance in advanced EGFR-mutant non-small cell lung cancer: Phase II ABCD-study. Lung cancer (Amsterdam, Netherlands) 2024 10 197 107988. Akito Hata, Nobuyuki Katakami, Naoto Takase, Kayoko Kibata, Yuta Yamanaka, Motohiro Tamiya, Masahide Mori, Takashi Kijima, Satoshi Morita, Kazuko Sakai, Kazuto Nish |
| Relationships of Proton Pump Inhibitor-Induced Renal Injury with CYP2C19 Polymorphism: A Retrospective Cohort Study. Clinical pharmacology and therapeutics 2024 1 . Rika Fukui, Satoshi Noda, Yoshito Ikeda, Yuichi Sawayama, Tomohiro Terada, Yoshihisa Nakagawa, Shin-Ya Mori |
- Page last reviewed:Feb 1, 2024
- Content source: